Over 3000 nurses gathered in New Orleans for the Oncology Nursing Society (ONS) 37th Annual Congress. Here are some of the video highlights from the conference, from OncLive TV:
Carol J. Bush, BS, RN, Patient Navigator, Midwest Cancer Alliance, The University of Kansas Cancer Center, discusses the telehealth network used by the Midwest Cancer Alliance (MCA) to provide access to the ONS Chemotherapy and Biotherapy training for oncology nurses in rural areas.
Krista Rubin, MS, RN, FNP-BC, Center for Melanoma, Massachusetts General Hospital Cancer Center, discusses the management of immune-mediated dermatitis, a common side effect of ipilimumab (Yervoy), an immunotherapy used to treat patients with advanced melanoma.
Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses the prognosis for patients with human papillomavirus (HPV)-positive squamous cell carcinoma of the head and neck.
Anna Vioral, MSN, MEd, RN, OCN®, Oncology, West Penn Allegheny Health System, summarizes a three year effort to standardize and integrate a set of multidisciplinary chemotherapy safety standards, which used the preexisting recommendations from the American Society of Clinical Oncology (ASCO) and Oncology Nursing Society (ONS).
Michael Eckenfels, BSN, LMSW, RN, OCN®, Lymphoma Myeloma Center, MD Anderson Cancer Center, discusses a nurse-led project that sought to reduce the incidence of bortezomib (Velcade)-related peripheral neuropathy in patients with multiple myeloma.
Mary Gullatte, PhD, RN, APRN, BC, AOCN®, FAAN, associate chief nursing officer, Emory University Hospital Midtown, president, Oncology Nursing Society, discusses the factors that contribute to nursing shortages and what may be behind an apparent lack of shortages.
Anne Katz, RN, PhD, editor, Oncology Nursing Forum, Manitoba Prostate Centre, University of Manitoba, CancerCare Manitoba, discusses the impact of cancer on sexual functioning and health, which can be connected to the tumor itself, effects of the treatment, emotions, or changes in a patient’s self image.
Jayshree Shah, RN, APN-C, MSN, BSN, BS, Nurse Practitioner, Leukemia Division, John Theurer Cancer Center, Hackensack University Medical Center, discusses the safety and efficacy of nilotinib (Tasigna), a selective BCR-ABL kinase inhibitor for patients with chronic myeloid leukemia (CML).
Kim Kelly, RN, OCN, Oncology, John Theurer Cancer Center, Hackensack University Medical Center, discusses the analysis that led to the new MASCC/ISOO clinical practice guidelines for managing mucositis, presented in an abstract at the 2012 ONS Annual Congress.
<<< View more from the 2012 ONS Congress